Caredx Lab Solutions Inc.
West Chester, PA Part of Caredx, Inc.
Company facts
- FY2025 rankings
-
Its parent company, Caredx, Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Brisbane, CA
Y371A27ZEUM4
-
Parent
Brisbane, CA
Y371A27ZEUM4
- SAM.gov registration date
- Physical address
- 901 S Bolmar St r, West Chester, PA 19382, USA
- Website
- caredx.com
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $286,980 |
| FY2025 | $465,162 |
| FY2024 | $457,783 |
| FY2023 | $524,390 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $292,973 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Gendx Products LLC | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Biocartis US Inc. | Itasca, IL | 334516 Analytical Laboratory Instrument Manufacturing |
| Natera Inc. | Austin, TX | 621511 Medical Laboratories |
| Karius, Inc. | Redwood City, CA | 621511 Medical Laboratories |
| Abbott Molecular Inc. | Des Plaines, IL | 325413 In-Vitro Diagnostic Substance Manufacturing |
About the company
Caredx Lab Solutions Inc., a West Chester, Pennsylvania-based subsidiary of Caredx, Inc., manufactures FDA-approved genomics-based diagnostic tests and next-generation sequencing reagent kits for federal healthcare and research agencies as a prime contractor, competing on technical capability without set-aside designations across 34 recent awards valued at $8.8 million combined potential.
The company specializes in transplant diagnostics, particularly the proprietary AlloMap molecular test for post-transplant heart recipients and AlloSeq TX17 next-generation sequencing reagent kits for HLA typing and immunosuppression assessment. Caredx Lab Solutions operates as a manufacturer and diagnostic service provider, with performance split between its West Chester headquarters and a Rockville, Maryland facility. The company has competed exclusively as a full-and-open prime contractor on individual purchase orders and delivery orders; no subcontract work or set-aside activity appears in the source.
Customer concentration skews toward NIH Clinical Center and the Department of Veterans Affairs, but with notable value concentration at the Army Medical Command. The NIH Clinical Center accounts for 14 awards (41% of total awards) with $1.2 million combined potential value, including purchase orders for AlloSeq TX17 NGS reagent kits valued at $243 thousand, $279 thousand, and $292 thousand awarded in 2023–2026. Veterans Integrated Service Network 17 holds six awards with $956 thousand combined potential value, anchored by a $787,000 single-award indefinite delivery contract (awarded June 3, 2022, running through June 2027) for AlloMap molecular testing services; five delivery orders issued under this IDC between June 2022 and June 2026 ranged from $6,480 to $59,932 per order. The Department of the Navy Bureau of Medicine and Surgery placed four awards totaling $689 thousand, including a $200,000 purchase order with the Naval Medical Research Command's Bone Marrow Program (July 2025–July 2026) and a $250,000 sole-source purchase order for Stage 1 optimization reagents supporting NGS assay development for hematopoietic stem cell transplant protocols (June 2024). The Department of Health and Human Services Centers for Disease Control and Prevention awarded two orders for ASTX17.1 testing kits totaling $260 thousand. Two Army Medical Command awards carry $5.5 million combined potential value, significantly outweighing other customer relationships by dollar magnitude, though their scope and contract type are not detailed in the source.
Award activity has declined year over year — five awards in 2022 declining to two in 2026 — and three awards with combined potential value of $553 thousand face ultimate completion within the next twenty-four months, triggering recompete exposure on the VA VISN 17 IDC and related purchase orders. The company holds positions on an indefinite delivery contract (36C25722D0051) with five task orders totaling $169 thousand and a blanket purchase agreement (W91YTZ11A0042) with one $27,000 task order. No parent vehicles such as GWACs or agency-wide IDIQs are listed; work flows through agency-specific contracts and IDCs. Performance categories reflect the company's manufacturing footprint: Research and Development in Biotechnology (8 awards), Medical Laboratories (6 awards), Analytical Laboratory Instrument Manufacturing (5 awards), and In-Vitro Diagnostic Substance Manufacturing (3 awards). The company's federal business is narrowly focused on transplant diagnostics, reagent supply, and specialized molecular testing services to support organ transplant care across the VA, NIH Clinical Center, DoD medical facilities, and CDC.
Quick answers
Is Caredx Lab Solutions Inc. registered in SAM.gov?
Yes. Caredx Lab Solutions Inc.'s SAM.gov registration is active through May 18, 2027.
What is Caredx Lab Solutions Inc.'s CAGE code?
Caredx Lab Solutions Inc.'s CAGE code is 6E5A4, and its Unique Entity ID (UEI) is KHHBJ9FJR225.
How much has Caredx Lab Solutions Inc. received in federal contracts?
Federal contracts obligated $465,162 to Caredx Lab Solutions Inc. in fiscal year 2025 and $1,734,315 in fiscal years 2023 through 2027.
How does Caredx Lab Solutions Inc. rank among federal contractors?
Caredx Lab Solutions Inc.'s parent company, Caredx, Inc., ranked #21 in PSC AN41 and #55 in PSC 6550 in FY2025.
What is Caredx Lab Solutions Inc.'s most recent federal award?
Caredx Lab Solutions Inc.'s most recent federal contract award is Caredx allomap (36C25726N0188), from Veterans Integrated Service Network 17 (VHA), on June 3, 2026.
On GovTribe
See Caredx Lab Solutions Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors